Praxis Precision Medicines Inc


Market Cap$366.09M

Compare Praxis Precision Medicines

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Praxis Precision Medicines IncPraxis Precision Medicines Inc00%---
marketMarket Avg49.61.28%30%6.11.1
HealthcareHealthcare Avg32.71.25%19%7.40.9

Share Statistics

Market cap$366.09 Million
Enterprise Value-
Dividend Yield$0.0 (0.0%)
Earnings per Share$0.0
Outstanding Shares8,791,877
Avg 30 Day Volume110,912


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio0.0
Price to Sales-
Price to Book Ratio-
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income-
Total Debt to Enterprise-
Debt to Equity-

Revenue Sources

No data

ESG Score

No data

About Praxis Precision Medicines Inc

2,020 employees

Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders (CNS) characterized by neuronal imbalance. Praxis is applying in...